Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE: 300832)

Shenzhen New Industries Biomedical Engineering Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	568.7	1,048	483.43	617.58	1,075	1,980
Short-Term Investments	-	275.79	110.09	-	-	-
Trading Asset Securities	2,017	2,080	2,814	2,806	2,300	-
Cash & Short-Term Investments	2,586	3,404	3,407	3,424	3,375	1,980
Cash Growth	-20.50%	-0.09%	-0.49%	1.46%	70.44%	38.33%
Accounts Receivable	903.84	631.78	479.97	276.1	218.35	227.68
Other Receivables	11.94	80.66	42.83	12.69	2.77	6.52
Receivables	915.78	712.44	522.79	288.79	221.13	234.2
Inventory	996.31	916.79	839.33	645.38	459.29	236.77
Prepaid Expenses	11.18	7.44	32.29	104.75	48.32	20.07
Other Current Assets	157.76	23.09	20.8	34.16	21.48	13.78
Total Current Assets	4,667	5,064	4,822	4,497	4,125	2,485
Property, Plant & Equipment	1,545	1,442	1,325	1,134	803.51	568.87
Long-Term Investments	1,758	924.95	357.62	136.9	-	-
Other Intangible Assets	246.29	169.46	172.48	94.56	98.91	102.59
Long-Term Accounts Receivable	279.1	189.17	93.85	28.1	-	-
Long-Term Deferred Tax Assets	57.26	37.94	22.9	12.14	22.73	8.25
Long-Term Deferred Charges	157.44	156.69	69.08	74.97	77.56	78.16
Other Long-Term Assets	126.79	238.22	150.77	157.39	178.06	214.96
Total Assets	8,836	8,222	7,015	6,136	5,306	3,458
Accounts Payable	196.24	126.99	176.68	171.35	98.26	54.17
Accrued Expenses	128.47	187.77	149.03	124.27	121.78	98.24
Current Portion of Leases	1.47	1.69	1.32	1.35	-	-
Current Income Taxes Payable	141.02	120.35	76.19	59.92	95.9	68.24
Current Unearned Revenue	63.93	91.48	108.94	77.08	71.06	45.43
Other Current Liabilities	67.47	63.2	71.78	73.96	105.74	42.3
Total Current Liabilities	598.61	591.48	583.94	507.94	492.74	308.37
Long-Term Leases	3.07	3.49	0.89	0.88	-	-
Long-Term Unearned Revenue	49.22	33.06	5.81	6.58	8.74	10.55
Long-Term Deferred Tax Liabilities	66.22	50.06	24.41	8.11	-	-
Total Liabilities	717.12	678.09	615.06	523.51	501.49	318.92
Common Stock	785.72	785.72	786.13	786.66	412.35	370.4
Additional Paid-In Capital	1,332	1,332	1,348	1,450	1,601	239.28
Retained Earnings	5,971	5,374	4,267	3,411	2,850	2,529
Treasury Stock	-	-	-16.29	-37.51	-58.55	-
Comprehensive Income & Other	29.62	52.7	13.99	1.64	-0.33	-0.08
Shareholders' Equity	8,119	7,544	6,399	5,612	4,804	3,139
Total Liabilities & Equity	8,836	8,222	7,015	6,136	5,306	3,458
Total Debt	4.54	5.18	2.22	2.24	-	-
Net Cash (Debt)	2,581	3,399	3,405	3,422	3,375	1,980
Net Cash Growth	-20.50%	-0.17%	-0.49%	1.40%	70.44%	38.33%
Net Cash Per Share	3.29	4.33	4.33	4.35	4.50	2.81
Filing Date Shares Outstanding	785.72	785.72	786.13	786.66	783.47	703.76
Total Common Shares Outstanding	785.72	785.72	786.13	786.66	783.47	703.76
Working Capital	4,068	4,473	4,238	3,989	3,632	2,177
Book Value Per Share	10.33	9.60	8.14	7.13	6.13	4.46
Tangible Book Value	7,873	7,375	6,227	5,517	4,705	3,036
Tangible Book Value Per Share	10.02	9.39	7.92	7.01	6.01	4.31
Buildings	-	1,061	541.55	516.8	504.42	425.06
Machinery	-	659.08	512.48	427.32	313.43	236.2
Construction In Progress	-	169.32	605.7	442.99	172.23	35.67

Source: S&P Capital IQ. Standard template. Financial Sources.